Volatile anesthetics reduce biochemical markers of brain injury and brain magnesium disorders in patients undergoing coronary artery bypass graft surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 26, Issue 3, 2012, Pages 395-402

  Dabrowski, Wojciech ^a   Rzecki, Ziemowit ^a   Czajkowski, Marek ^a   Pilat, Jacek ^a   Wacinski, Piotr ^a   Kotlinska, Edyta ^a   Sztanke, Magorzata ^a   Sztanke, Krzysztof ^a   Stazka, Krzysztof ^a   Pasternak, Kazimierz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

coronary artery bypass graft surgery; extracorporeal circulation; glial fibrillary acidic protein; isoflurane; magnesium; matrix metalloproteinase 9; sevoflurane

Indexed keywords

GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; ISOFLURANE; MAGNESIUM; SEVOFLURANE;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN CIRCULATION; BRAIN INJURY; BRAIN MAGNESIUM DISORDER; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE MARKER; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPSYCHOLOGY; OBSERVATIONAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

AGED; ANESTHETICS, INHALATION; BIOLOGICAL MARKERS; BRAIN; BRAIN INJURIES; CORONARY ARTERY BYPASS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; ISOFLURANE; MAGNESIUM; MALE; MATRIX METALLOPROTEINASE 9; METHYL ETHERS; MIDDLE AGED; NEUROPROTECTIVE AGENTS;

EID: 84861096416     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2011.10.014     Document Type: Article

References (67)

1. Y.Q. Yin, A.L. Luo, X.Y. Gio Postoperative neuropsychological change and its underlying mechanism in patients undergoing coronary artery bypass grafting Chin Med J Engl 120 2007 1951 1957
2. H.P. Grocott Characteristics, incidence and pathomechanisms of neurological damage during cardiac surgery Appl Cardiopulm Pathophysiol 13 2009 20 26
3. M.F. Newman, J.L. Kirchner, B.S. Phillips-Bute Longitudinal assessment of neurocognitive function after coronary artery bypass surgery N. Engl. J. Med 344 2001 395 402
4. D.I. Bulas, G.A. Taylor, R.M. O'Donnell Intracranial abnormalities in infants treated with extracorporeal membrane oxygenation: Update on sonographic and CT findings AJNR Am J Neuroradiol 17 1996 287 294
5. M. Herrmann, A.D. Ebert, I. Galazky Neurobehavioral outcome prediction after cardiac surgery Role of neurobiochemical markers of damage to neuronal and glial brain tissue Stroke 31 2000 645 650
6. H. Jönsson S100B and cardiac surgery Possibilities and limitations Restor Neurol Neurosci 21 2003 151 157
7. H. Jönsson, P. Johnsson, M. Bäckström Controversial significance of early S100B levels after cardiac surgery BMC Neurol 4 2004 24 31
8. J.R. Turner, R. Vink Magnesium in the central nervous system Y. Nishizawa, H. Morri, J. Durlach, New Perspectives in Magnesium Research, Nutrition and Health 2007 Springer London 338 355
9. R. Vink, I. Cernak Regulation of intracellular free magnesium in central nervous system injury Front Biosci 5 2000 656 665
10. W.W. Oppelt, I. Maclntyre, D.P. Rall Magnesium exchange between blood and cerebrospinal fluid Am J Physiol 205 1963 959 962
11. D.L. Heath, R. Vink Brain free magnesium concentration is predictive of motor outcome following traumatic axonal brain injury in rats Magnes Res 12 1999 269 277
12. C. van den Heuvel, R. Vink The role of magnesium in traumatic brain injury Clin Calcium 14 2004 9 14
13. D.F. Feng, Z.A. Zhu, Y.C. Lu Effect of magnesium sulfate on traumatic brain edema in rats Chin J Traumatol 7 2004 148 152
14. L.A. Dzyak, T.I. Duka, A.L. Drozov Glial fibrillary acidic protein in rat brain structures under conditions of training for passive defensive habit Neurophysiology 31 1999 290 291
15. L.E. Pelinka, A. Kroepfl, R. Schmidhammer Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma J Trauma 57 2004 1006 1012
16. P.E. Vos, K.J.B. Lamers, J.C.M. Hendriks Glial and neuronal proteins in serum predict outcome after traumatic brain injury Neurology 62 2004 1303 1310
17. G.A. Rosenberg Martix metalloproteinases and their multiple roles in neurodegenerative diseases Lancet Neurol 8 2009 205 216
18. S. Mun-Bryce, G.A. Rosenberg Matrix metalloproteinases in cerebrovascular disease J Cereb Blood Flow Metab 18 1998 1163 1172
19. M. Grossetete, J. Phelps, L. Arko Elevation of matrix metalloproteinase 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury Neurosurgery 65 2009 702 708
20. J. Haorah, S.H. Ramirez, K. Schall Oxidative stress activates protein tyrosine kinase and matrix metalloproteinase leading to blood-brain barrier dysfunction J Neurochem 101 2007 566 576
21. D. Ishigaki, K. Ogasawara, Y. Suga Concentration of matrix metalloproteinase -9 in the jugular bulb during carotid endarterectomy correlates with severity of intraoperative cerebral ischemia Cerebrovasc Dis 25 2008 587 592
22. S.K. Bhudia, D.M. Cosgrove, R.I. Nagle Magnesium as a neuroprotectant in cardiac surgery: A randomized clinical trial J Thorac Cardiovasc Surg 131 2006 853 861
23. H.P. Grocott Pharmacological prevention and modulation of cerebral ischemia and neurological dysfunction during cardiac surgery Appl Cardiopulm Pathophysiol 13 2009 27 33
24. W. Dabrowski, Z. Rzecki, J. Wosko Volatile anaesthetics reduce serum S100 concentrations in patients undergoing elective cardiac surgery Appl Cardiopulm Pathophysiol 14 2010 139 148
25. T. Westermaier, S. Zausinger, A. Baethmann Dose findings study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats Acta Neurochir 147 2005 525 532
26. S. Wang, Z.G. Dai, X.W. Dong Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase Neurosci Bull 26 2010 437 444
27. B.L. Sullivan, D. Leu, D.M. Taylor Isoflurane prevents delayed cell death in an organotypic slice culture model of cerebral ischemia Anesthesiology 96 2002 189 195
28. J.L. Codaccioni, L.J. Velly, C. Moubarik Sevoflurane preconditioning against focal cerebral ischemia Anesthesiology 110 2009 1271 1278
29. W. Dabrowski, Z. Rzecki, M. Czajkowski Plasma matrix metalloproteinase 9 correlates with disorders of brain magnesium homeostasis in patients undergoing coronary artery bypass surgery Magnes Res 23 2010 169 179
30. T. Ozgurtas, S. Khraman State of the art of new data on the role of magnesium in brain injury: Clinical interest of measurements of total and ionized magnesium Magnes Res 17 2004 327 334
31. R. Vink, N.L. Cook, C. van den Heuvel Magnesium in acute and chronic brain injury: An update Magnes Res 22 2009 158S 162S
32. F.M. Bareyre, K.E. Saatman, M.A. Helfaer Alterations in ionized and total blood magnesium after experimental traumatic brain injury: Relationship to neurobehavioral outcome and neuroprotective efficacy of magnesium chloride J Neurochem 73 1999 271 280
33. K. Deckardt, I. Weber, U. Kaspers The effects of inhalation anaesthetics on common clinical pathology parameters in laboratory rats Food Chem Toxicol 45 2007 1709 1718
34. P.E. Bickler, C.S. Fahlman The inhaled anesthetic, isoflurane, enhances Ca + - Dependent survival signalling in cortical neurons and modulates MAP kinases, apoptosis protein and transcription factors during hypoxia Anesth Analg 103 2006 419 429
35. R. Bains, M.C. Moe, G.A. Larsen Volatile anaesthetics depolarize neural mitochondria by inhibition of the electron transport chain Acta Anaesthesiol Scand 50 2006 572 579
36. 2+ and mitogen-activated protein kinases Anesthesiology 102 2005 606 615
37. P.E. Bickler, X. Zhan, C.S. Fahlman Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation Role of intracellular Ca2+ and mitogen-activated protein kinase signalling Anesthesiology 103 2005 532 539
38. L. Xiong, Y. Zheng, M. Wu Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate- regulated potassium channels after focal cerebral ischemia in rats Anesth Analg 96 2003 233 237
39. R. Saski, K. Hirota, S.H. Roth Extracellular magnesium ion modifies the actions of volatile anesthetics in area CA1 of rat hippocampus in vitro Anesthesiology 96 2002 681 687
40. U. Dirnagl, R.P. Simon, J.M. Hallenbeck Ischemic tolerance and endogenous neuroprotection Trends Neurosci 26 2003 248 254
41. K.R. Dave, I. Saul, R. Busto Ischemic preconditioning preserves mitochondrial function after global cerebral ischemia in rat hippocampus J Cereb Blood Flow Metab 21 2001 1401 1410
42. Z. Guo, X. Sun, Z. He Role of matrix metalloproteinase 9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage Neurol Sci 31 2010 143 149
43. T. Gorkiewicz, K. Szczuraszek, P. Wyrembek Matrix metalloproteinases-9 reversibly affects the time course of NMDA-induced currents in cultured rat hippocampal neurons Hippocampus 20 2010 1105 1108
44. S.R. Lee, K. Tsuji, S.R. Lee Role of matrix metalloproteinase in delayed neuronal damage after transient global cerebral ischemia J Neurosci 24 2004 678-671
45. H.A.T. Lee Volatile anesthetics and cardiac surgery Appl Cardiopulm Pathophysiol 11 2007 40 46
46. S. Kon, M. Imai, H. Inaba Isoflurane attenuates early neutrophil-independent hypoxia-reoxygenation injuries in reperfused liver in fasted rats Anesthesiology 86 1997 128 136
47. B. Heidl, F.M. Reichle, S. Zahler Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils Anesthesiology 91 1999 521 530
48. R. Liu, Y. Ishibe, M. Udea Isoflurane - Sevoflurane administration before ischemia attenuates ischemia-reperfusion-induced injury of isolated rat lungs Anesthesiology 92 2000 833 840
49. K.M. Lumpkins, G.V. Bochicchio, K. Keledjian Glial fibrillary acidic protein is highly correlated with brain injury J Trauma 65 2008 778 784
50. P.E. Vos, K.J.B. Lamers, J.C.M. Hendriks Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury Neurology 62 2004 1303 1310
51. F. Dvorak, I. Haberer, M. Sitzer Characterisation of diagnostic window of serum glial fibrillary acidic protein for the differentiation if intracerebral haemorrhage and ischaemic stroke Cerebrovasc Dis 27 2009 37 41
52. F. Mielck, A. Stephan Weyland, A. Weyland Effects of one minimum alveolar anesthetic concentration sevoflurane on cerebral metabolism, blood flow and CO2 reactivity in cardiac patients Anesth Analg 89 1999 364 369
53. M.S. Scheller, K. Nakakimura, J.E. Fleischer Cerebral effects of sevoflurane in dog: Comparison with isoflurane and enflurane Br J Anaesth 65 1990 388 392
54. T. Hayashi, Y. Kaneko, S. Yu Quantitative analyses of matrix metalloproteinase activity after brain traumatic injury in adult rats Brain Res 1280 2009 172 177
55. A. Vilalta, J. Sahuquillo, A. Rosell Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases Intensive Care Med 34 2008 1384 1392
56. M. Kanbak, F. Saricaoglu, A. Avci Propofol offers no advantage over isoflurane anesthesia for cerebral protection during cardiopulmonary bypass: A preliminary study of S100β protein levels Can J Anaesth 51 2004 712 717
57. B. Liu, G. Yu, Z. Yang Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction J Int Med Res 37 2009 601 610
58. T. Fujiwara, S. Saito, T. Osanai Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin Eur J Pharmacol 594 2008 146-145
59. B.I. Jugdutt, A. Jelani, A. Palaniyappan Aging-related early changes in markers of ventricular and matrix remodeling after reperfused ST-segment elevation myocardial infarction in the canine model: Effect of early therapy with an angiotensin II type 1 receptor blocker Circulation 122 2010 341 351
60. N. Mahajan, N. Malik, A. Bahl Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease Mol Cell Biochem 330 2009 201 209
61. S. Miyazaki, T. Kasai, K. Miyauchi Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both Circ J 74 2010 1158 1164
62. Z.X. Ye, H.B. Leu, T.C. Wu Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease Clin Biochem 41 2008 292 298
63. J. Paśnik, A. Cywiska-Bernas, J. Moll Alterations of metalloproteinases and their inhibitors concentrations in peripheral blood in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass Przegl Lek 66 2009 359 364
64. J.W. Olney, C. Young, D.F. Wozniak Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci 25 2004 135 139
65. H. Wei, G. Liang, H. Yang Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity Nuerosci Lett 425 2007 59 62
66. H. Wei, B. Kang, W. Wei Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently Brain Res 1037 2005 139 147
67. W. Dabrowski Magnesium supplementation significantly reduces serum S100β concentrations in patients who have undergone coronary artery bypass surgery Magnes Res 22 2009 21 31